Galectin Therapeutics Files Registration Statement for Stockholder Rights Offering of Common Stock and Warrants

Author's Avatar
Mar 06, 2019
Article's Main Image

Richard E. Uihlein, Board Chair, expresses interest in investing $20.0 million in the Rights Offering